logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
Á

Ángel Guerrero-Zotano

instituto valenciano de oncología
H指数:25
被引数:4,073

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Trop-2 overexpression as a prognostic marker in early triple-negative breast cancer: results from the GEICAM_CIBOMA trial

Trop-2过表达作为早期三阴性乳腺癌的预后标志物：GEICAM_CIBOMA试验的结果

Breast Cancer Research
IF5.6
2026-08-280
OA
Federico Rojo; Sara Lopez-Tarruella; Begoña Bermejo; Laura Torrecillas; Manuel Ruiz-Borrego; Jose Bines; Jose G. M. Segalla; Jose A. Garcia-Saenz; Roberto Torres; Juan de la Haba-Rodriguez; Elena Garcia-Martinez; Henry Gomez; Antonio Llombart-Cussac; Maria Rodriguez de la Borbolla; Laura Perez Michel; Margarita Amenedo; Isaura Fernandez; Alvaro Rodriguez-Lescure; Jesus Cardenas; Jeferson Vinholes; Eduardo Martinez de Dueñas; Vega Iranzo Gonzalez-Cruz; Miguel Angel Segui; Sandra Perez-Buira; Jesus Herranz; Raul Rincon; Rosalia Caballero; Carlos H. Barrios; Miguel Martin; Angel Guerrero-Zotano
Dynamic thymidine kinase activity independently captures treatment-specific biological response and is independently associated with outcomes in endocrine-resistant HR+/HER2− metastatic breast cancer: a translational analysis of the GEICAM/2013-02 PEARL trial

动态胸苷激酶活性独立捕获治疗特异性的生物学反应，并与内分泌耐药的HR+/HER2−转移性乳腺癌的结局独立相关：GEICAM/2013-02 PEARL试验的转化分析

European Journal of Cancer
IF7.1
2026-05-250
OAAI
Ángel Guerrero-Zotano; Miguel Gil-Gil; Amy Williams; Manuel Ruiz-Borrego; Hanna Ritzén; Eva María Ciruelos; Montserrat Muñoz; Begoña Bermejo; Mireia Margelí; Antonio Antón; Zsuzsanna Kahan; Tibor Csöszi; Laura Murillo; Serafín Morales Murillo; Istvan Lang; Cristina Reboredo Rendo; Emilio Alba; Pablo Álvarez; Juan de la Haba-Rodriguez; Isabel Álvarez
A chemotherapy-free, pathological response-adapted strategy using trastuzumab–pertuzumab and T-DM1 in HER2-positive early breast cancer: the PHERGain-2 study☆

一种基于曲妥珠单抗–帕妥珠单抗和T-DM1的病理反应适应策略在HER2阳性早期乳腺癌中的应用：PHERGain-2研究☆

Annals of Oncology
IF65.4
2026-05-060
OA
L. Garrigós; M. Ruiz-Borrego; J.M. Pérez-García; A. Guerrero-Zotano; A. Cortés-Salgado; S. Kuemmel; M. Colleoni; C. Reboredo-Rendo; B. Bermejo; I. Blancas; J. Gavila; A. Fabi; C. Morales; A. Stradella; V. Carañana; E. Martínez-de Dueñas; C. Albacar; O. Ballesteros-Cidras; G. Martrat; S. Iacobucci
A Retrospective Observational Study of Extended Adjuvant Neratinib for HER2-Positive Early-Stage Breast Cancer in a European Early Access Program

一项在欧洲早期准入计划中对HER2阳性早期乳腺癌进行延长辅助尼妥珠单抗治疗的回顾性观察研究

Oncology and Therapy
IF3.2
2025-10-290
OA
Marija Križić; Tajana Silovski; Griet Hoste; Natalija Dedić Plavetić; Olivier Romano; Xavier González Farre; Alicia Cano Jimenez; Angel Guerrero Zotano; Jeanne Suissa; Farida Beghdad; Olivia Dialla; Marta Zivanov; Michelino De Laurentiis
Intermediate endpoints as surrogates for long-term outcomes in breast cancer adjuvant chemotherapy trials

中间终点作为长期结局的替代指标在乳腺癌辅助化疗试验中的应用

ONCOLOGIST
IF4.2
2025-09-010
OAAI
Blasco, Andrea; Lopez-Tarruella, Sara; Urruticoechea, Ander; Carrasco, Eva; Spera, Gonzalo; Martin, Miguel; Bermejo, Begona; Chap, Linnea; Ruiz-Borrego, Manuel; Crown, John; Garcia-Saenz, Jose A.; Chan, Arlene; Guerrero-Zotano, Angel; Semiglazov, Vladimir; Calvo, Lourdes; Pienkowski, Tadeusz; Herranz, Jesus; Slamon, Dennis
TIM3+ breast cancer cells license immune evasion during micrometastasis outbreak

TIM3⁺乳腺癌细胞在微转移爆发期间促进免疫逃逸

Cancer Cell
IF44.5
2025-07-100
OAAI
Catalina Rozalén; Irene Sangrador; Silvia Avalle; Sandra Blasco-Benito; Panagiota Tzortzi; María Sanz-Flores; José Ángel Palomeque; Pau Torren-Duran; Mariona Dalmau; Helena Brunel; Albert Coll-Manzano; Iván Pérez-Núñez; Tamara Martos; Sonia Servitja; Sandra Pérez-Buira; José Ignacio Chacón; Ángel Guerrero-Zotano; Eduardo Martínez de Dueñas; Yolanda Guillén; Laura Comerma; Begoña Bermejo; Anna Bigas; María Casanova-Acebes; Anna Alemany; Federico Rojo; Joan Albanell; Toni Celià-Terrassa
Body mass index as a predictive factor for efficacy of adjuvant taxane-based chemotherapy in early-stage breast cancer patients: A pooled analysis from adjuvant GEICAM Spanish Breast Cancer Group and TRIO Translational Research in Oncology Group studies
INTERNATIONAL JOURNAL OF CANCER
IF4.7
2025-04-100
OAAI
Garcia-Saenz, Jose A.; Spera, Gonzalo; Pollan, Marina; Bermejo, Begona; Ruiz-Borrego, Manuel; Chan, Arlene; Martin, Miguel; Guerrero-Zotano, Angel; Calvo, Lourdes; Rodriguez-Lescure, Alvaro; Marin, Maria; Chap, Linnea; Crown, John; Pienkowski, Tadeusz; Bee, Valerie; Casas, Maribel; Polonio, Oscar; Bezares, Susana; Slamon, Dennis
Neoadjuvant letrozole and palbociclib in patients with HR-positive/HER2-negative early breast cancer and Oncotype DX Recurrence Score ≥18: DxCARTES study
ESMO OPEN
IF8.3
2024-10-010
OAAI
Guerrero-Zotano, A.; Perez-Garcia, J. M.; Ruiz-Borrego, M.; Bermejo, B.; Gil-Gil, M.; de la Haba, J.; Conejo, E. Alba; Quiroga, V; Caranana, V; Urruticoechea, A.; Morales, S.; Bellet, M.; Anton, A.; Fernandez-Abad, M.; Sanchez-Rovira, P.; Calabuig, L.; Perez-Escuredo, J.; Sampayo-Cordero, M.; Cortes, J.; Llombart-Cussac, A.
Cross-sectional and longitudinal associations of adherence to WCRF/AICR cancer prevention recommendations with health-related quality of life in breast cancer survivors. Health-EpiGEICAM study
JOURNAL OF NUTRITION HEALTH & AGING
IF4
2024-08-011
OAAI
Lope, Virginia; Guerrero-Zotano, Angel; de Larrea-Baz, Nerea Fernandez; Antolin, Silvia; Vinuales, Marta Benavent; Bermejo, Begona; Ruiz-Moreno, Emma; Baena-Canada, Jose Manuel; Paris, Lorena; Anton, Antonio; Chacon, Jose Ignacio; Munoz, Montserrat; Garcia-Saenz, Jose Angel; Olier, Clara; Rovira, Pedro Sanchez; Lanza, Angels Arcusa; Gonzalez, Sonia; Brunet, Joan; Oltra, Amparo; Bezares, Susana; Rosell, Libertad; Perez-Gomez, Beatriz; Pastor-Barriuso, Roberto; Martin, Miguel; Pollan, Marina
Adding atezolizumab to adjuvant chemotherapy for stage II and III triple-negative breast cancer is unlikely to improve efficacy: interim analysis of the ALEXANDRA/IMpassion030 phase 3 trial
CANCER RESEARCH
IF16.6
2024-05-023
PRE
Ignatiadis, Michail; Bailey, Andrew; McArthur, Heather; El-Abed, Sarra; de Azambuja, Evandro; Metzger, Otto; Chui, Steve; Dieterich, Max; Perretti, Thomas; Steger, Guenther; Jassem, Jacek; Lee, Soo Chin; Higgins, Michaela; Zarba, Jose; Schmidt, Marcus; Gomez, Henry; Guerrero-Zotano, Angel; Moscetti, Luca; Chiu, Joanne Win Yang; DuFrane, Carter; Honvault, Vanessa; Altarcheh, Rosa; Molinero, Luciana; Ellingson, Andrew; Munzone, Elisabetta; Ben-Baruch, Noa Efrat; Bajetta, Emilio; Ohno, Shinji; Im, Seock-Ah; Werutsky, Gustavo; Gal-Yam, Einav; Gonzalez-Farre, Xavier; Tseng, Ling-Ming; Jacot, William; Gluz, Oleg; Shao, Zhimin; Shparyk, Yaroslav; Sinielnikov, Ivan; Anastasia, Zimina; Vasiliev, Aleksandr; Shearer-Kang, Esther; Winer, Eric; Martins-Branco, Diogo; Fielding, Shona; Cameron, David; Viale, Giuseppe; Saji, Shigehira; Gelber, Richard; Piccart, Martine
Clinical and Genomic Features of ER-Positive/HER2-negative Metastatic Breast Cancer in AURORA Molecular Screening Initiative (BIG 14-01): Mechanisms of Endocrine Therapy Resistance and Implications for Adjuvant Approaches
CANCER RESEARCH
IF16.6
2024-05-020
PRE
Guerrero-Zotano, Angel; Benelli, Matteo; Irrthum, Alexandre; Cameron, David; Ferrando, Lorenzo; Romagnoli, Dario; Paoli, Marta; Llinas, Arnau; Dadiani, Maya; Fimereli, Danai; Oliveira, Mafalda; Caballero, Carmela; Crestani, Thayane; Agostinetto, Elisa; Martins-Branco, Diogo; Hilbers, Florentine; Gal-Yam, Einav; Balic, Marija; Cardoso, Fatima; Reis-Filho, Jorge; Sotiriou, Christos; Curigliano, Giuseppe; Linderholm, Barbro; de Azambuja, Evandro; Knox, Susan; Rotaru, Cristina; Ciruelos, Eva; Davidson, Nancy E.; Viale, Giuseppe; Taylor, Donatienne; Canon, Jean-Luc; Calvo, Lourdes; Albanell, Joan; Colleoni, Marco; Duhem, Caroline; Harbeck, Nadia; Herremans, Catherine; Loibl, Sibylle; Marreaud, Sandrine; Scheepers, Elsemieke; Raimbault, Alice; Goulioti, Theodora; Vingiani, Andrea; Biagioni, Chiara; Vosberg, Sebastian; Zoppoli, Gabriele; Seoane, Jose; Venet, David; Aftimos, Philippe; Piccart, Martine
Neratinib plus fulvestrant plus trastuzumab for HR-positive, HER2-negative, HER2-mutant metastatic breast cancer: outcomes and biomarker analysis from the SUMMIT trial
ANNALS OF ONCOLOGY
IF65.4
2023-10-0123
OAAI
Jhaveri, K.; Eli, L. D.; Wildiers, H.; Hurvitz, S. A.; Guerrero-Zotano, A.; Unni, N.; Brufsky, A.; Park, H.; Waisman, J.; Yang, E. S.; Spanggaard, I.; Reid, S.; Burkard, M. E.; Vinayak, S.; Prat, A.; Arnedos, M.; Bidard, F. -C.; Loi, S.; Crown, J.; Bhave, M.; Piha-Paul, S. A.; Suga, J. M.; Chia, S.; Saura, C.; Garcia-Saenz, J. a.; Gambardella, V.; de Miguel, M. J.; Gal-Yam, E. N.; Raphael, A.; Stemmer, S. M.; Ma, C.; Hanker, A. B.; Ye, D.; Goldman, J. W.; Bose, R.; Peterson, L.; Bell, J. S. K.; Frazier, A.; Diprimeo, D.; Wong, A.; Arteaga, C. L.; Solit, D. B.
Real-world data of Advanced Breast Cancer (ABC) patients with HER2-positivity before the second-line therapy: data from the observational study GEICAM/2014-03 (RegistEM)
CANCER RESEARCH
IF16.6
2023-03-010
PRE
Lopez-Tarruella, Sara; Guerrero-Zotano, Angel; Cruz, Josefina; Novoa, Silvia Antolin; Martinez, Purificacion; Hernandez, Maria; Rodriguez, Cesar A.; Chacon, J. Ignacio; Tibau, Ariadna; Falo, Catalina; Rodriguez-Lescure, Alvaro; Margeli, Mireia; Servitja, Sonia; Andres, Raquel; Galan-Gramaje, Maria; Adrover, Encarna; Miguel, Ana; Villanueva, Rafael; Varela, Silvia; Campo, Ruth; Escudero, Ma Jose; Bezares, Susana; Rojo, Federico; Alvarez, Isabel
Features and survival outcomes of HER2-low patients from a prospective registry of unresectable locally advanced or metastatic breast cancer: GEICAM/2014-03 (RegistEM)
CANCER RESEARCH
IF16.6
2023-03-010
PRE
Alvarez, Isabel; Guerrero-Zotano, Angel; Tibau, Ariadna; Falo, Catalina; Hernandez, Maria; Miguel, Ana; Andres, Raquel; Rodriguez-Lescure, Alvaro; Corbellas, Miguel; Lopez-Tarruella, Sara; Martinez, Purificacion; Rodriguez, Cesar A.; Malon, Diego; Marin, Maria; Echarri, Ma Jose; Anton, Antonio; Cruz, Josefina; Moreno, Diana; Chacon, J. Ignacio; Campo, Ruth; Blasco, Andrea; Bezares, Susana; Rojo, Federico; Antolin, Silvia
Treatment strategies for advanced triple negative breast cancer patients as per routine clinical practice: analysis from the observational study GEICAM/2014-03 (RegistEM)
CANCER RESEARCH
IF16.6
2023-03-010
PRE
Novoa, Silvia Antolin; Rodriguez, Cesar A.; Cruz, Josefina; Lopez-Tarruella, Sara; Tibau, Ariadna; Adrover, Encarna; Miguel, Ana; Margeli, Mireia; Martinez, Purificacion; Hernandez, Maria; Anton, Antonio; Rodriguez-Lescure, Alvaro; Falo, Catalina; Alvarez, Isabel; Malon, Diego; Andres, Raquel; Alonso-Romero, Jose L.; Gomez, Cesar; Illaramendi, J. Jose; Campo, Ruth; Miralles, Juan Jose; Bezares, Susana; Rojo, Federico; Guerrero-Zotano, Angel
CCNE1 and PLK1 Mediate Resistance to Palbociclib in HR+/HER2-Metastatic Breast Cancer

CCNE1和PLK1介导HR /HER2-Metastatic乳腺癌对Palbociclib的耐药性

CLINICAL CANCER RESEARCH
IF10.2
2023-02-0716
OAAI
Guerrero-Zotano, Angel; Belli, Stefania; Zielinski, Christoph; Gil-Gil, Miguel; Fernandez-Serra, Antonio; Ruiz-Borrego, Manuel; Gil, Eva Maria Ciruelos; Pascual, Javier; Munoz-Mateu, Montserrat; Bermejo, Begon; Vila, Mireia Margeli; Anton, Antonio; Murillo, Laura; Nissenbaum, Bella; Liu, Yuan; Herranz, Jesus; Fernandez-Garcia, Daniel; Caballero, Rosalia; Lopez-Guerrero, Jose Antonio; Bianco, Roberto; Formisano, Luigi; Turner, Nicholas; Martin, Miguel
Triple-Negative PAM50 Non-Basal Breast Cancer Subtype Predicts Benefit from Extended Adjuvant Capecitabine
CLINICAL CANCER RESEARCH
IF10.2
2022-11-089
OAAI
Asleh, Karama; Lluch, Ana; Goytain, Angela; Barrios, Carlos; Wang, Xue Q.; Torrecillas, Laura; Gao, Dongxia; Ruiz-Borrego, Manuel; Leung, Samuel; Bines, Jose; Guerrero-Zotano, Angel; Garcia-Saenz, Jose Angel; Cejalvo, Juan Miguel; Herranz, Jesus; Torres, Roberto; de la Haba-rodriguez, Juan; Ayala, Francisco; Gomez, Henry; Rojo, Federico; Nielsen, Torsten O.; Martin, Miguel
Type does matter. Use VIRGIN olive oil as your preferred fat to reduce your risk of breast cancer: case-control EpiGEICAM study
European Journal of Clinical Nutrition
IF3.3
2022-02-222
PRE
Donat-Vargas, Carolina; Guerrero-Zotano, Angel; Lope, Virginia; Bermejo, Begona; Casas, Ana; Baena-Canada, Jose Manuel; Antolin, Silvia; Sanchez-Rovira, Pedro; Anton, Antonio; Garcia-Saenz, Jose Angel; Ramos, Manuel; Munoz, Montserrat; de Juan, Ana; Jara Sanchez, Carlos; Chacon, Jose Ignacio; Gil-Gil, Miguel; Andres Conejero, Raquel; Llombart, Antonio; Bezares, Susana; Fernandez de Larrea-Baz, Nerea; Perez-Gomez, Beatriz; Martin, Miguel; Pollan, Marina
Neratinib plus fulvestrant plus trastuzumab for hormone receptor-positive, HER2-mutant metastatic breast cancer and neratinib plus trastuzumab for triple-negative disease: Latest updates from the SUMMIT trial
CANCER RESEARCH
IF16.6
2022-02-156
PRE
Jhaveri, Komal; Park, Haeseong; Waisman, James; Goldman, Jonathan W.; Guerrero-Zotano, Angel; Boni, Valentina; Haley, Barbara; Mayer, Ingrid A.; Brufsky, Adam; Yang, Eddy S.; Garcia-Saenz, Jose A.; Bidard, Francois-Clement; Crown, John; Zhang, Bo; Frazier, Aimee; Diala, Irmina; Eli, Lisa D.; Barnett, Brian; Wildiers, Hans
Features of HER2+metastasic patients (pts) from a prospective registry of advanced breast cancer (ABC), GEICAM/2014-03 (RegistEM)
CANCER RESEARCH
IF16.6
2022-02-150
PRE
Alvarez, Isabel; Guerrero-Zotano, Angel; Cruz, Josefina; Martinez, Purificacion; Hernandez, Maria; Rodriguez, Cesar A.; Rodriguez-Lescure, Alvaro; Antolin, Silvia; Adrover, Encarna; Andres, Raquel; Falo, Catalina; Chacon, Jose Ignacio; Miguel, Ana; Servitja, Sonia; Gramaje, Maria Galan; Vila, Mireia Margeli; Raposo, Cesar Gomez; Echarri, Maria Jose; Villanueva, Rafael; Martorell, Ariadna Tibau; Ferreiro, Silvia Varela; Campo, Ruth; Miralles, Juan Jose; Bezares, Susana; Rojo, Federico; Lopez-Tarruella, Sara

研究方向

暂未获取到该数据
B
Begoña Bermejo
H 指数:41论文数:635被引数:6,649
S
Silvia Antolín
H 指数:26论文数:167被引数:2,885
L
Luigi Formisano
H 指数:35论文数:317被引数:4,380
J
José Á. García-Sáenz
H 指数:51论文数:521被引数:1.4万
C
Carlos L. Arteaga
H 指数:123论文数:1,310被引数:5.5万
F
Federico Rojo
H 指数:71论文数:782被引数:2.3万
J
José Ignacio Chacón
H 指数:24论文数:175被引数:3,414
S
Susana Bezares
H 指数:11论文数:72被引数:972
M
Miguel Martín
H 指数:107论文数:1,252被引数:4.6万
S
Sara López‐Tarruella
H 指数:28论文数:249被引数:2,743